Unexplained infertility: controversies in diagnosis and management

1. Practice Committee of the American Society for Reproductive Medicine. Evidence-based reatments for couples with unexplained infertility: a guideline. Fertil. Steril. 2020; 113(2):305-322. https://dx.doi.org/10.1016/j.fertnstert.2019.10.014.
2. Guideline Group on Unexplained Infertility; Romualdi D., Ata B., Bhattacharya S., Bosch E., Costello M., Gersak K. et al. Evidence-based guideline: unexplained infertility. Hum. Reprod. 2023; 38(10): 1881-90. https://dx.doi.org/10.1093/humrep/dead150.
3. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Женское бесплодие. 2021. 120с. [Ministry of Health of the Russian Federation. Clinical guidelines. Female infertility. 2021. 120p. (in Russian)].
4. Zegers-Hochschild F., Adamson G.D., Dyer S., Racowsky C., de Mouzon J., Sokol R. et al. The International Glossary on Infertility and Fertility Care, 2017. Hum. Reprod. 2017; 32(9): 1786-801. https://dx.doi.org/10.1093/humrep/dex234.
5. Bhattacharya S., Porter M., Amalraj E., Templeton A., Hamilton M., Lee A.J. et al. The epidemiology of infertility in the North East of Scotland. Hum. Reprod. 2009; 24(12): 3096-107. https://dx.doi.org/10.1093/humrep/dep287.
6. Kamath S.M., Bhattacharya S. Demographics of infertility and management of unexplained infertility. Best Pract. Res. Clin. Obstet. Gynaecol. 2012; 26(6): 729-38. https://dx.doi.org/10.1016/j.bpobgyn.2012.08.001.
7. Паскарь С.С., Боярский К.Ю. Эпидемиологические аспекты бесплодного брака (обзор литературы). Проблемы репродукции. 2017; 23(5): 23 6. [Paskar S.S., Boiarsky K.Yu. The epidemiological aspects of infertile marriage (a review). Russian Journal of Human Reproduction. 2017; 23(5): 23-6. (in Russian)]. https://dx.doi.org/10.17116/repro201723523-26.
8. Корнеева И.Е., Назаренко Т.А., Перминова С.Г., Митюрина Е.В., Цыбизова Т.И., Дашиева А.Э. Медико-социальные факторы бесплодия в России. Акушерство и гинекология. 2023; 3: 65-72. [Korneeva I.Е., Nazarenko Т.А., Perminova S.G., Mityurina E.V., Cybizova T.I., Dashieva A.E. Medical and social factors of infertility in Russia. Obstetrics and Gynecology. 2023; (3): 65-72 (in Russian)]. https://dx.doi.org/10.18565/aig.2022.279.
9. Raperport С., Desai J., Qureshi D., Rustin E., Balaji А., Chronopoulou E. et al. The definition of unexplained infertility: A systematic review; BJOG. 2024; 131(7): 880-97. https://dx.doi.org/10.1111/1471-0528.17697.
10. Costello M.F., Norman R.J., Rombauts L., Farquhar C.M., Bedson L., Kong M. et al.; Australian NHMRC Centre for Research Excellence in Reproductive Life UI Guideline Network and the ESHRE guideline group for unexplained infertility. Recommendations from the 2024 Australian evidence-based guideline for unexplained infertility: ADAPTE process from the ESHRE evidence-based guideline on unexplained infertility. Med. J. Aust. 2024; 221(8): 438-46. https://dx.doi.org/10.5694/mja2.52437.
11. Somigliana E., Paffoni A., Busnelli A., Filippi F., Pagliardini L., Vigano P. et al. Age-related infertility and unexplained infertility: an intricate clinical dilemma. Hum. Reprod. 2016; 31(7): 1390-6. https://dx.doi.org/10.1093/humrep/dew066.
12. Gaskins A.J., Sundaram R., Buck Louis G.M., Chavarro J.E. Predictors of sexual intercourse frequency among couples trying to conceive. J. Sex. Med. 2018; 15(4): 519-28. https://dx.doi.org/10.1016/j.jsxm.2018.02.005.
13. Gamoudi D., Flew S., Cusini M., Benardon S., Poder A., Radcliffe K. European STI guidelines and routine screening. Sex. Transm. Inf. 2018; 94(4): 281-7.
14. Киракосян Е. Эмбриологические особенности программ экстракорпорального оплодотворения у пациентов с бесплодием неясного генеза. Армянский журнал здравоохранения и медицинских наук. 2024; 4-2: 82-8. [Kirakosyan Ye. Emriological features of in vitro fertilization programs in patients with unexplained infertility. Armenian Journal of Helth & Medical Sciences. 2024; (4-2): 82-8. (in Russian)]. https://dx.doi.org/10.54235/27382737-2024.v4.2-82.
15. National Institute for Health and Care Excellence (NICE). Fertility: assessment and treatment for people with fertility problems. London: NICE; 2013.
16. Backet J., Sierra S. The management of unexplained infertility: an evidence-based guideline from the Canadian Fertility and Andrology Society. Reprod. Biomed. 2019; 39(4):633-40. https://dx.doi.org/10.1016/j.rbmo.2019.05.023.
17. Lai S., Wang R., van Wely M., Costello M., Farquhar C., Bensdorp A.J. et al. IVF versus IUI with ovarian stimulation for unexplained infertility: a collaborative individual participant data meta-analysis. Hum. Reprod. Update. 2024; 30(2): 174-85. https://dx.doi.org/10.1093/humupd/dmad033.
18. Wang R., Danhof N.A., Tjon-Kon-Fat R.I., Eijkemans M.J., Bossuyt P.M., Mochtar M.H. et al. Interventions for unexplained infertility: a systematic review and network meta-analysis. Cochrane Database Syst. Rev. 2019; 9(9): CD012692. https://dx.doi.org/10.1002/14651858.CD012692.pub2.
19. Nandi A., Raja G., White D., Tarek E.T. Intrauterine insemination + controlled ovarian hyperstimulation versus in vitro fertilisation in unexplained infertility: a systematic review and meta-analysis. Arch. Gynecol. Obstet. 2022; 305(4): 805-24. https://dx.doi.org/10.1007/s00404-021-06277-3.
20. Reindollar R.H., Regan M.M., Neumann P.J., Levine B.S., Thornton K.L., Alper M.M. et al. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial. Fertil. Steril. 2010; 94(3): 888-99. https://dx.doi.org/10.1016/j.fertnstert.2009.04.022.
21. Elzeiny H., Garrett C., Toledo M., Stern K., McBain J., Baker H.W. A randomised controlled trial of intra-uterine insemination versus in vitro fertilisation in patients with idiopathic or mild male infertility. Aust. N. Z. J. Obstet. Gynaecol. 2014; 54(2): 156-61. https://dx.doi.org/10.1111/ajo.12168.
22. Goldman M.B., Thornton K.L., Ryley D., Alper M.M., Fung J.L., Hornstein M.D. et al. A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T). Fertil. Steril. 2014; 101(6): 1574-81.e1-2. https://dx.doi.org/10.1016/j.fertnstert.2014.03.012.
23. Chiu Y.H., Yland J.J., Rinaudo P., Hsu J., McGrath S., Hernández-Díaz S. et al. Effectiveness and safety of intrauterine insemination vs. assisted reproductive technology: emulating a target trial using an observational database of administrative claims. Fertil. Steril. 2022; 117(5): 981-91. https://dx.doi.org/10.1016/j.fertnstert.2022.02.003.
24. Kim D., Child T., Farquhar C. Intrauterine insemination: a UK survey on the adherence to NICE clinical guidelines by fertility clinics. BMJ. 2015; 5(5): e007588. https://dx.doi.org/10.1136/bmjopen-2015-007588
25. Wessel J.A., Hunt S., van Wely M., Mol F., Wang R. Alternatives to in vitro fertilization. Fertil. Steril. 2023; 120(3 Pt 1): 483-93. https://dx.doi.org/10.1016/j.fertnstert.2023.01.011.
26. van Weert J.M., van den Broek J., van der Steeg J.W., van der Veen F., Flierman P.A., Mol B.W. et al. Patients' preferences for intrauterine insemination or in-vitro fertilization. Reprod. Biomed. Online. 2007; 15(4): 422-7. https://dx.doi.org/10.1016/s1472-6483(10)60368-9.
27. Duffy J.M.N., Adamson G.D., Benson E., Bhattacharya S., Bhattacharya S., Bofill M. et al.; Priority Setting Partnership for Infertility. Top 10 priorities for future infertility research: an international consensus development study. Hum. Reprod. 2020; 35(12): 2715-24. https://dx.doi.org/10.1093/humrep/deaa242.
28. Au L.S., Feng Q., Shingshetty L., Maheshwari A., Mol B.W. Evaluating prognosis in unexplained infertility. Fertil. Steril. 2024; 121(5): 717-29. https://dx.doi.org/10.1016/j.fertnstert.2024.02.044.
29. Здановский В.М., Краснопольская К.В., Ляхов А.В., Воскобоева Е.Ю. Вспомогательные репродуктивные технологии, некоторые клинико-эмбриологические и генетические аспекты женского бесплодия неясного генеза. Проблемы репродукции. 2022; 28(2): 59-67. [Zdanovskiy V.M., Krasnopol’skaya K.V., Lyakhov A.V., Voskoboeva E.Y. Unexplained female infertility and ART: clinic, embryology, genetic items. Russian Journal of Human Reproduction. 2022; 28(2): 59-67. (in Russian)]. https://dx.doi.org/10.17116/repro20222802159.
30. Бачурин А.В., Киракосян Е.В., Назаренко Т.А., Павлович С.В. Анализ эмбриологического этапа программ экстракорпорального оплодотворения у пациентов с бесплодием неясного генеза. Акушерство и гинекология. 2022; 9: 81-6. [Bachurin A.V., Kirakosyan E.V., Nazarenko N.A., Pavlovich S.V. Analysis of the embryonic stage of in vitro fertilization programs in patients with unexplained infertility. Obstetrics and Gynecology. 2022; (9): 81-6 (in Russian)]. https://dx.doi.org/10.18565/aig.2022.9.81-86.
31. Hershlag A., Paine T., Kvapil G., Feng H., Napolitano B. In vitro fertilization-intracytoplasmic sperm injection split: an insemination method to prevent fertilization failure. Fertil. Steril. 2002; 77(2): 229-32. https://dx.doi.org/10.1016/s0015-0282(01)02978-8.
32. Johnson L.N., Sasson I.E., Sammel M.D., Dokras A. Does intracytoplasmic sperm injection improve the fertilization rate and decrease the total fertilization failure rate in couples with well-defined unexplained infertility? A systematic review and meta-analysis. Fertil. Steril. 2013; 100(3): 704-11. https://dx.doi.org/10.1016/j.fertnstert.2013.04.038.
33. Foong S.C., Fleetham J.A., O’Keane J.A., Scott S.G., Tough S.C., Greene C.A. A prospective randomized trial of conventional in vitro fertilization versus intracytoplasmic sperm injection in unexplained infertility. J. Assist. Reprod. Genet. 2006; 23(3):137-40. https://dx.doi.org/10.1007/s10815-005-9008-y.
34. Iwamoto A., Summers K., Sparks A., Mancuso A.С. Intracytoplasmic sperm injection versus conventional in vitro fertilization in unexplained infertility. Fertil. Steril. 2024; 5(3): 263-71. https://dx.doi.org/10.1016/j.xfre.2024.06.003
35. Solovova O.A., Chernykh V.B., Ivanov A.N. Genetics of oocyte maturation defects and early embryo development arrest. Genes (Basel). 2022; 13(11): 1920. https://dx.doi.org/10.3390/genes13111920.
36. Salfati E.L., Spencer E.G., Topol S.E., Muse E.D., Rueda M., Lucas J.R. et al. Re-analysis of whole-exome sequencing data uncovers novel diagnostic variantsand improves molecular diagnostic yields for sudden death and idiopathic diseases. Genome Med. 2019; 11(1): 83. https://dx.doi.org/10.1186/s13073-019-0702-2.
37. Логутова Л.С., Краснопольская К.В., Воскобоева Е.Ю., Ляхов А.В. Генетические особенности пациенток с бесплодием неясного генеза. Российский вестник акушера-гинеколога. 2023; 23(5): 19-24. [Logutova L.S., Krasnopol’skaya K.V., Voskoboeva E.Yu., Lyakhov A.V. Genetic features of patients with infertility of unclear genesis. Russian Bulletin of Obstetrician-Gynecologist. 2023; 23(5): 19-24. (in Russian)]. https://dx.doi.org/10.17116/rosakush20232305119.
38. Киракосян Е.В., Померанцева Е.А., Павлович С.В. Полноэкзомное секвенирование супружеских пар с бесплодием неясного генеза (пилотное исследование). Акушерство и гинекология. 2022; 12: 115-21. [Kirakosyan E.V., Pomerantseva E.A., Pavlovich S.V. Whole exome sequencing in couples with unexplained infertility (pilot study). Obstetrics and Gynecology. 2022; (12): 115-21 (in Russian)]. https://dx.doi.org/10.18565/aig.2022.247
39. Feng R., Yan Z., Li B., Yu M., Sang Q., Tian G. et al. Mutations in TUBB8 cause a multiplicity of phenotypes in human oocytes and early embryos. J. Med. Genet. 2016; 53(10): 662-71. https://dx.doi.org/10.1136/jmedgenet-2016-103891.
40. Lanuza-López M.C., Martínez-Garza S.G., Solórzano-Vázquez J.F., Paz-Cervantes D., González-Ortega C., Maldonado-Rosas I. et al. Oocyte maturation arrest produced by TUBB8 mutations: impact of genetic disorders in infertility treatment. Gynecol. Endocrinol. 2020; 36(9): 829-34. https://dx.doi.org/10.1080/09513590.2020.1725968.
41. Huang L., Tong X., Luo L., Zheng S., Jin R., Fu Y. et al. Mutation analysis of the TUBB8 gene in nine infertile women with oocyte maturation arrest. Reprod. Biomed. Online. 2017; 35(3): 305-10. https://dx.doi.org/10.1016/j.rbmo.2017.05.017.
42. Chen B., Li B., Li D., Yan Z., Mao X., Xu Y. et al. Novel mutations and structural deletions in TUBB8: expanding mutational and phenotypic spectrum of patients with arrest in oocyte maturation, fertilization or early embryonic development. Hum. Reprod. 2017; 32(2): 457-64. https://dx.doi.org/10.1093/humrep/dew322.
43. Liu Z., Zhu L., Wang J., Luo G., Xi Q., Zhou X. et al. Novel homozygous mutations in PATL2 lead to female infertility with oocyte maturation arrest. J. Assist. Reprod. Genet. 2020; 37(4): 841-7. https://dx.doi.org/10.1007/s10815-020-01698-6.
44. Zhao H., Chen Z.J., Qin Y., Shi Y., Wang S., Choi Y. et al. Transcription factor FIGLA is mutated in patients with premature ovarian failure. Am. J. Hum. Genet. 2008; 82(6): 1342-8. https://dx.doi.org/10.1016/j.ajhg.2008.04.018.
45. Zhang Y., Ho K., Keaton J.M., Hartzel D.N., Day F., Justice A.E. et al. A genome-wide association study of polycystic ovary syndrome identified from electronic health records. Am. J. Obstet. Gynecol. 2020; 223(4): 559.e1-559.e21. https://dx.doi.org/10.1016/j.ajog.2020.04.004
46. Okutman Ö., Demirel C., Tülek F., Pfister V., Büyük U., Muller J. et al. Homozygous splice site mutation in ZP1 causes familial oocyte maturation defect. Genes (Basel). 2020; 11(4): 382. https://dx.doi.org/10.3390/genes11040382.
47. Maddirevula S., Awartani K., Coskun S., AlNaim L.F., Ibrahim N., Abdulwahab F. et al. A genomics approach to females with infertility and recurrent pregnancy loss. Hum. Genet. 2020; 139(5): 605-13. https://dx.doi.org/10.1007/s00439-020-02143-5.
48. Chen T., Bian Y., Liu X., Zhao S., Wu K., Yan L. et al. A recurrent missense mutation in ZP3 causes empty follicle syndrome and female infertility. Am. J. Hum. Genet. 2017; 101(3): 459-65. https://dx.doi.org/10.1016/j.ajhg.2017.08.001.
49. Dai C., Hu L., Gong F., Tan Y., Cai S., Zhang S. et al. ZP2 pathogenic variants cause in vitro fertilization failure and female infertility. Genet. Med. 2019; 21(2): 431-40. https://dx.doi.org/10.1038/s41436-018-0064-y.
50. Xu Y., Shi Y., Fu J., Yu M., Feng R., Sang Q. et al. Mutations in PADI6 cause female infertility characterized by early embryonic arrest. Am. J. Hum. Genet. 2016; 99(3): 744-52. https://dx.doi.org/10.1016/j.ajhg.2016.06.024.
51. Zhang L., Bao Y., Riaz M., Tiller J., Liew D., Zhuang X. et al. Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis. Genet. Med. 2019; 21(9): 1958-68. https://dx.doi.org/10.1038/s41436-019-0457-6.
52. Alazami A.M., Awad S.M., Coskun S., Al-Hassan S., Hijazi H., Abdulwahab F.M. et al. TLE6 mutation causes the earliest known human embryonic lethality. Genome Biol. 2015; 16: 240. https://dx.doi.org/10.1186/s13059-015-0792-0.
53. Wang X., Jin H.R., Cui Y.Q., Chen J., Sha Y.W., Gao Z.L. Case study of a patient with cryptozoospermia associated with a recessive TEX15 nonsense mutation. Asian J. Androl. 2018; 20(1): 101-2. https://dx.doi.org/10.4103/1008-682X.194998.
54. Mu J., Wang W., Chen B., Wu L., Li B., Mao X. et al. Mutations in NLRP2 and NLRP5 cause female infertility characterised by early embryonic arrest. J. Med. Genet. 2019; 56(7): 471-80. https://dx.doi.org/10.1136/jmedgenet-2018-105936.
55. Xu J., Niu W., Peng Z., Bao X., Zhang M., Wang L. et al. Comparative study of single-nucleotide polymorphism array and next generation sequencing based strategies on triploid identification in preimplantation genetic diagnosis and screen. Oncotarget. 2016; 7(49): 81839-48. https://dx.doi.org/10.18632/oncotarget.13247.
56. Xu Y., Qian Y., Liu Y., Wang Q., Wang R., Zhou Y. et al. A novel homozygous variant in NLRP5 is associate with human early embryonic arrest in a consanguineous Chinese family. Clin. Genet. 2020; 98(1): 69-73. https://dx.doi.org/10.1111/cge.13744.
57. Wang W., Dong J., Chen B., Du J., Kuang Y., Sun X. et al. Homozygous mutations in REC114 cause female infertility characterised by multiple pronuclei formation and early embryonic arrest. J. Med. Genet. 2020; 57(3): 187-94. https://dx.doi.org/10.1136/jmedgenet-2019-106379.
58. Dawes R., Lek M., Cooper S.T. Gene discovery informatics toolkit defines candidate genes for unexplained infertility and prenatal or infantile mortality. NPJ Genom. Med. 2019; 4: 8. https://dx.doi.org/10.1038/s41525-019-0081-z.

Received 19.12.2024

Accepted 27.12.2024